Modulation of cathepsin G expression in severe atopic dermatitis following medium-dose UVA1 phototherapy

BMC Dermatology

Volumn 2, Issue , 2002, Pages

  Breuckmann, Frank ^a   von Kobyletzki, Gregor ^a   Avermaete, Annelies ^a   Kreuter, Alexander ^a   Altmeyer, Peter ^a   Gambichler, Thilo ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN G; COLLAGEN TYPE 1; EMOLLIENT AGENT; FIBRONECTIN; LAMININ; MONOCLONAL ANTIBODY; PROTEINASE; PROTEOGLYCAN; TISSUE INHIBITOR OF METALLOPROTEINASE; CATHEPSIN; CD3 ANTIGEN; SERINE PROTEINASE;

ARTICLE; ATOPIC DERMATITIS; BASEMENT MEMBRANE; CELL MEMBRANE PERMEABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MODULATION; PHOTOTHERAPY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RADIATION DOSE; SKIN BIOPSY; SKIN INFILTRATE; SKIN INFLAMMATION; ULTRAVIOLET A RADIATION; BIOPSY; CLINICAL TRIAL; IMMUNOLOGY; METABOLISM; PATHOLOGY; SKIN;

ANTIGENS, CD3; BIOPSY; CATHEPSINS; DERMATITIS, ATOPIC; HUMANS; IMMUNOHISTOCHEMISTRY; SERINE ENDOPEPTIDASES; SKIN; ULTRAVIOLET THERAPY;

EID: 2942625619     PISSN: 14715945     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-5945-2-12     Document Type: Article

References (17)

1. Leung DYM: The skin as a window into the pathogenesis of chronic allergic diseases. J Allergy Clin Immunol 1995, 96:302-319
2. Rothe MJ, Grant-Kels JM: Atopic dermatitis: An update. J Am Acad Dermatol 1996, 35:1-13
3. Kowalzick L, Kleinheinz A, Weichenthal M, et al: Low dose versus medium dose UV-A1 treatment in severe atopic eczema. Acta Derm Venereol 1995, 75:43-45
4. von Kobyletzki G, Freitag M, Herde M, et al: Phototherapy of severe atopic dermatitis: Comparison between conventional UVA1 phototherapy, UVA1. cold light phototherapy and combined UVA-UVB phototherapy. Hautarzt 1999, 50:27-33
5. Krutmann J, Czech W, Diepgen T, et al: High-dose UVA1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol 1992, 26:225-230
6. Breuckmann F, Pieck C, Kreuter A, et al: Opposing effects of UVA1 phototherapy on the expression of bcl-2 and p53 in atopic dermatitis. Arch Dermatol Res 2001, 293:178-183
7. Tani K, Ogushi F, Shimizu T, et al: Protease-induced leukocyte chemotaxis and activation: roles in host defense and inflammation. J Med Invest 2001, 48(3-4):133-141
8. Cooper KD: Atopic Dermatitis: Recent trends in pathogenesis and therapy. J Invest Dermatol 1994, 102:128-137
9. Hanifin JM, Rajka G: Diagnostic features of atopic dermatitis. Acta Derm Venerol 1980, 92:44-47
10. European Task Fore on Atopic Dermatitis: Severity scoring of atopic dermatitis: The SCORAD index. Dermatology 1993, 186:23-31
11. Okada Y, Nakanishi I: Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 ('gelatinase') by human neutrophil elastase and cathepsin G. FEBS Lett 1989, 249(2):353-356
12. Liotta LA: Tumor invasion and metastases: role of the extracellular matrix. Cancer Res 1986, 46:1-7
13. Capodici C, Muthukumaran G, Amoruso MA, et al: Activation of neutrophil collagenase by cathepsin G. Inflammation 1989, 13(3):245-258
14. Bruch M, Landwehr R, Engel J: Dissection of laminin by cathepsin G into its long-arm and short-arm structures and localization of regions involved in calcium dependent stabilization and self-association. Eur J Biochem 1989, 185:271-279
15. Kirk TZ, Mark ME, Chua CC, et al: Myofibroblasts from scleroderma skin synthesize elevated levels of collagen and tissue inhibitor of metalloproteinase (TIMP-1) with two forms of TIMP-1. J Biol Chem 1995, 270:3423-3428
16. Scharffetter-Kochanek K, Wlaschek M, Hogg A, et al: UVA irradiation induces collagenase in human dermal fibroblasts in vitro and in vivo. Arch Dermatol Res 1991, 283:506-511
17. Biggs JR, Yang J, Gullberg U, et al: The human brm protein is cleaved during apoptosis: The role of cathepsin G. Proc Natl Acad Sci 2001, 98(7):3814-3819